Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Be the Bridge Between Researchers and a Cure (GVHD, ALS, Hepatitis B, Alzheimer's Disease, Leukemia, and More)

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2014 by Sanguine Biosciences
Sponsor:
Information provided by (Responsible Party):
Sanguine Biosciences
ClinicalTrials.gov Identifier:
NCT01931644
First received: August 23, 2013
Last updated: June 10, 2014
Last verified: June 2014

August 23, 2013
June 10, 2014
July 2013
August 2020   (final data collection date for primary outcome measure)
Biospecimen & Clinical Data Collection [ Time Frame: 10 years ] [ Designated as safety issue: No ]
To collect enough biospecimens and associated clinical data to allow researchers to come to statistically relevant scientific results
Same as current
Complete list of historical versions of study NCT01931644 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Be the Bridge Between Researchers and a Cure (GVHD, ALS, Hepatitis B, Alzheimer's Disease, Leukemia, and More)
A Multi-Site Tissue Repository Providing Annotated Biospecimens for Approved Investigator-Directed Biomedical Research Initiatives

At Sanguine, we consider ourselves the bridge between patients and researchers striving to find new treatments and diagnostics for numerous medical conditions. We collect biospecimens like blood for medical researchers. Donate from your home, track your sample, and help advance medical research.

This study will collect blood and other optionally donated tissue samples from people with all different types of health conditions, as well as healthy control samples, in order to provide biomedical researchers with quality biospecimens that are necessary in translating basic science research into clinically relevant information and technology.

Observational
Observational Model: Cohort
Time Perspective: Cross-Sectional
Not Provided
Retention:   Samples With DNA
Description:

Whole blood, serum, plasma, PBMC, RNA, DNA, saliva, stool, hair, skin, CSF, synovial fuid, tumor tissue, urine

Probability Sample

Diagnosed with a health condition

All Diagnosed Health Conditions
Not Provided
  • Health Condition
    Collect blood and other optional biospecimens from participants with a diagnosed health condition
  • Healthy Control
    Collect blood and other optional biospecimens from participants that have not been diagnosed with a health condition
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
20000
December 2040
August 2020   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • All adults 18-100 years old
  • Able to provide proof of diagnosis
  • Live in USA

Exclusion Criteria:

  • Younger than 18 years old
  • Receipt of blood products within 30 days of study blood collection
  • Receipt of investigational drug within 30 days of study blood collection
Both
18 Years and older
Yes
Contact: Carlyn Crisostomo, MBA 877-864-3053 donors@sanguinebio.com
Contact: Kristen Warren, MBS 877-864-3053 study@sanguinebio.com
United States
 
NCT01931644
SAN-BB-01
No
Sanguine Biosciences
Sanguine Biosciences
Not Provided
Principal Investigator: Carlyn Crisostomo Sanguine Biosciences
Sanguine Biosciences
June 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP